MYOD1 (L122R) mutations are associated with spindle cell and sclerosing rhabdomyosarcomas with aggressive clinical outcomes.

Rekhi, Bharat; Upadhyay, Pawan; Ramteke, Manoj P; Dutt, Amit

Rekhi, Bharat; Upadhyay, Pawan; Ramteke, Manoj P; Dutt, Amit.

Afiliação

Rekhi B; Department of Surgical Pathology, Tata Memorial Centre, Parel, Mumbai, Maharashtra, India.
Upadhyay P; Integrated Genomics Laboratory, Advanced Centre for Treatment, Research and Education In Cancer, Tata Memorial Centre, Navi Mumbai, Maharashtra, India.
Ramteke MP; Homi Bhabha National Institute, Training School Complex Anushakti Nagar, Mumbai, India.
Dutt A; Integrated Genomics Laboratory, Advanced Centre for Treatment, Research and Education In Cancer, Tata Memorial Centre, Navi Mumbai, Maharashtra, India.

Mod Pathol ; 29(12): 1532-1540, 2016 12.

Article em En | MEDLINE | ID: mdl-27562493

Assuntos

Biomarcadores Tumorais/genética; Proteína MyoD/genética; Rabdomiossarcoma/genética; Adolescente; Adulto; Idoso; Criança; Pré-Escolar; Feminino; Humanos; Masculino; Pessoa de Meia-Idade; Mutação; Rabdomiossarcoma/patologia; Adulto Jovem

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Rabdomiossarcoma / Biomarcadores Tumorais / Proteína MyoD Tipo de estudo: Risk_factors_studies Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google